130 related articles for article (PubMed ID: 9415596)
1. Efficacy of repeated botulinum toxin injections as a function of timing.
Inagi K; Ford CN; Rodriquez AA; Schultz E; Bless DM; Heisey DM
Ann Otol Rhinol Laryngol; 1997 Dec; 106(12):1012-9. PubMed ID: 9415596
[TBL] [Abstract][Full Text] [Related]
2. Transoral electromyographic recordings in botulinum toxin-injected rat larynges.
Inagi K; Rodriquez AA; Ford CN; Heisey DM
Ann Otol Rhinol Laryngol; 1997 Nov; 106(11):956-64. PubMed ID: 9373087
[TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin management of adductor spasmodic dysphonia after failed recurrent laryngeal nerve section.
Sulica L; Blitzer A; Brin MF; Stewart CF
Ann Otol Rhinol Laryngol; 2003 Jun; 112(6):499-505. PubMed ID: 12834116
[TBL] [Abstract][Full Text] [Related]
4. Physiologic assessment of botulinum toxin effects in the rat larynx.
Inagi K; Connor NP; Ford CN; Schultz E; Rodriquez AA; Bless DM; Pasic T; Heisey DM
Laryngoscope; 1998 Jul; 108(7):1048-54. PubMed ID: 9665255
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): a 12-year experience in more than 900 patients.
Blitzer A; Brin MF; Stewart CF
Laryngoscope; 1998 Oct; 108(10):1435-41. PubMed ID: 9778279
[TBL] [Abstract][Full Text] [Related]
6. Spasmodic dysphonia combined with insufficient glottic closure by phonation.
Kaszás Z; Lichtenberger G; Mészáros K; Falvai J
Eur Arch Otorhinolaryngol; 2003 Sep; 260(8):418-20. PubMed ID: 12709812
[TBL] [Abstract][Full Text] [Related]
7. Effects of botulinum toxin on pathophysiology in spasmodic dysphonia.
Bielamowicz S; Ludlow CL
Ann Otol Rhinol Laryngol; 2000 Feb; 109(2):194-203. PubMed ID: 10685573
[TBL] [Abstract][Full Text] [Related]
8. Botox treatment in adductor spasmodic dysphonia: a meta-analysis.
Boutsen F; Cannito MP; Taylor M; Bender B
J Speech Lang Hear Res; 2002 Jun; 45(3):469-81. PubMed ID: 12069000
[TBL] [Abstract][Full Text] [Related]
9. Office-based endoscopic botulinum toxin injection in laryngeal movement disorders.
Kaderbay A; Righini CA; Castellanos PF; Atallah I
Eur Ann Otorhinolaryngol Head Neck Dis; 2018 Jun; 135(3):205-207. PubMed ID: 29661610
[TBL] [Abstract][Full Text] [Related]
10. Vocal aging and adductor spasmodic dysphonia: response to botulinum toxin injection.
Cannito MP; Kahane JC; Chorna L
Clin Interv Aging; 2008; 3(1):131-51. PubMed ID: 18488884
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of focal dystonia with botulinum toxin A].
Sojer M; Wissel J; Müller J; Poewe W
Wien Klin Wochenschr; 2001; 113 Suppl 4():6-10. PubMed ID: 15506045
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of spasmodic dysphonia with botulinum toxin].
Klap P; Marion MH; Perrin A; Fresnel-Elbaz E
Ann Otolaryngol Chir Cervicofac; 1991; 108(8):477-82; discussion 482-3. PubMed ID: 1789624
[TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin type A for treating voice tremor.
Adler CH; Bansberg SF; Hentz JG; Ramig LO; Buder EH; Witt K; Edwards BW; Krein-Jones K; Caviness JN
Arch Neurol; 2004 Sep; 61(9):1416-20. PubMed ID: 15364688
[TBL] [Abstract][Full Text] [Related]
14. The treatment of essential voice tremor with botulinum toxin A: a longitudinal case report.
Warrick P; Dromey C; Irish J; Durkin L
J Voice; 2000 Sep; 14(3):410-21. PubMed ID: 11021508
[TBL] [Abstract][Full Text] [Related]
15. Tremor laryngeal dystonia: treatment of the lateral cricoarytenoid muscle.
Maronian NC; Waugh PF; Robinson L; Hillel AD
Ann Otol Rhinol Laryngol; 2004 May; 113(5):349-55. PubMed ID: 15174760
[TBL] [Abstract][Full Text] [Related]
16. [Diagnostic and therapeutic difficulties in laryngeal dystonia].
Niebudek-Bogusz E; Modzelewska-Radwan B; Pietruszewska W; Zielińska M; Gryczyński M
Otolaryngol Pol; 2003; 57(5):739-45. PubMed ID: 14994622
[TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin treatment of false vocal folds in adductor spasmodic dysphonia: Functional outcomes.
Simpson CB; Lee CT; Hatcher JL; Michalek J
Laryngoscope; 2016 Jan; 126(1):118-21. PubMed ID: 26467807
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of botulinum toxin type B (Myobloc) in adductor spasmodic dysphonia.
Adler CH; Bansberg SF; Krein-Jones K; Hentz JG
Mov Disord; 2004 Sep; 19(9):1075-9. PubMed ID: 15372600
[TBL] [Abstract][Full Text] [Related]
19. Botulinum toxin injection for treatment of spasmodic dysphonia: experience at Srinagarind Hospital.
Srirompotong S; Saeseow P; Taweesaengsuksakul R; Kharmwan S; Srirompotong S
J Med Assoc Thai; 2006 Dec; 89(12):2077-80. PubMed ID: 17214059
[TBL] [Abstract][Full Text] [Related]
20. [Botulinum toxin efficacy in the treatment of patients with spasmodic dysphonia].
Svetel M; Vasić M; Tomić G; Stanković P; Stojanović M; Dragasević N; Dergenc R; Vukasinović M; Pekmezović T; Petrović I; Kostić V
Vojnosanit Pregl; 2007 Oct; 64(10):671-5. PubMed ID: 18041568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
